000 | 01076 a2200313 4500 | ||
---|---|---|---|
005 | 20250516084012.0 | ||
264 | 0 | _c20120626 | |
008 | 201206s 0 0 eng d | ||
022 | _a1522-9645 | ||
024 | 7 |
_a10.1093/eurheartj/ehs049 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLang, Irene M | |
245 | 0 | 0 |
_aPulmonary hypertension: chapters of innovation and tribulation. _h[electronic resource] |
260 |
_bEuropean heart journal _cApr 2012 |
||
300 |
_a961-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 | _aDrug Discovery |
650 | 0 | 4 | _aEarly Diagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension, Pulmonary _xgenetics |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisk Assessment |
700 | 1 | _aBenza, Raymond | |
773 | 0 |
_tEuropean heart journal _gvol. 33 _gno. 8 _gp. 961-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/ehs049 _zAvailable from publisher's website |
999 |
_c21653826 _d21653826 |